Payment overview · 2025
General Payments
$158,544.94
270 reported records · 19 companies
Healthcare provider profile · identity verified
John Moonkeun Park, MD
Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · OMAHA, NE · NPI 1023394665
Verified facts
What the public records show
CMS Open Payments records show John Moonkeun Park, MD received $158,544.94 in general payments during 2025 across 270 reported records.
Endologix LLC accounted for 49.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 50 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Endologix LLC | Unresolved — no canonical attribution shown | $77,936.61 | 49.2% | 75 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $43,499.75 | 27.4% | 72 | 2025 |
| Bard Peripheral Vascular, Inc. | Unresolved — no canonical attribution shown | $33,236.43 | 21.0% | 48 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $1,291.47 | 0.8% | 28 | 2025 |
| Cagent Vascular INC | Unresolved — no canonical attribution shown | $435.29 | 0.3% | 3 | 2025 |
| Artivion, Inc. | Unresolved — no canonical attribution shown | $418.99 | 0.3% | 8 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $363.75 | 0.2% | 13 | 2025 |
| Reflow Medical Inc | Unresolved — no canonical attribution shown | $303.22 | 0.2% | 3 | 2025 |
| AtriCure, Inc. | Unresolved — no canonical attribution shown | $179.59 | 0.1% | 2 | 2025 |
| Globus Medical, Inc. | Unresolved — no canonical attribution shown | $179.16 | 0.1% | 5 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$152.10 | 0.1% | 2 | 2025 |
| AngioDynamics, Inc. | Unresolved — no canonical attribution shown | $149.75 | 0.1% | 4 | 2025 |
| Shape Memory Medical Inc. | Unresolved — no canonical attribution shown | $146.67 | 0.1% | 1 | 2025 |
| Bolton Medical Inc | Unresolved — no canonical attribution shown | $136.58 | 0.1% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $34.55 | 0.0% | 1 | 2025 |
| Kerecis Limited | Unresolved — no canonical attribution shown | $26.10 | 0.0% | 1 | 2025 |
| Smith+Nephew, Inc. | Unresolved — no canonical attribution shown | $20.95 | 0.0% | 1 | 2025 |
| Becton, Dickinson and Company | Unresolved — no canonical attribution shown | $19.73 | 0.0% | 1 | 2025 |
| Philips North America LLC | Unresolved — no canonical attribution shown | $14.25 | 0.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $93,518.75 | 27 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $33,000.00 | 11 |
| Travel and Lodging | $19,354.27 | 71 |
| Food and Beverage | $12,671.92 | 161 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ENDOCROSS Device Normalized: endocross device |
Device | Endologix LLC | $71,753.60 | 55 | 2025 |
Source payment records
|
|||||
| Torus Stent Graft System Normalized: torus stent graft system |
Device | Endologix LLC | $71,753.60 | 55 | 2025 |
Source payment records
|
|||||
| General - Therapies Normalized: general therapies |
Device | Boston Scientific Corporation | $29,129.23 | 18 | 2025 |
Source payment records
|
|||||
| EkoSonic Normalized: ekosonic |
Device | Boston Scientific Corporation | $10,627.64 | 23 | 2025 |
Source payment records
|
|||||
| AFX2 Bifurcated Endograft System Normalized: afx2 bifurcated endograft system |
Device | Endologix LLC | $4,154.89 | 10 | 2025 |
Source payment records
|
|||||
| General - Vascular Intervention Normalized: general vascular intervention |
Device | Boston Scientific Corporation | $3,274.82 | 15 | 2025 |
Source payment records
|
|||||
| RotarexS 6 F x 135 cm Normalized: rotarexs 6 f x 135 cm |
Device | Bard Peripheral Vascular, Inc. | $2,931.50 | 10 | 2025 |
Source payment records
|
|||||
| Alto Abdominal Stent Graft System Normalized: alto abdominal stent graft system |
Device | Endologix LLC | $1,771.58 | 8 | 2025 |
Source payment records
|
|||||
| Ovation iX Iliac Stent Graft Normalized: ovation ix iliac stent graft |
Device | Endologix LLC | $1,295.35 | 2 | 2025 |
Source payment records
|
|||||
| GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis Normalized: gore excluder thoracoabdominal branch endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $930.77 | 11 | 2025 |
Source payment records
|
|||||
| Pristine Normalized: pristine |
Device | Bard Peripheral Vascular, Inc. | $585.64 | 1 | 2025 |
Source payment records
|
|||||
| Crosser IQ Normalized: crosser iq |
Device | Bard Peripheral Vascular, Inc. | $584.67 | 1 | 2025 |
Source payment records
|
|||||
| Venclose Maven Catheter Normalized: venclose maven catheter |
Device | Bard Peripheral Vascular, Inc. | $569.19 | 3 | 2025 |
Source payment records
|
|||||
| Denali Vena Cava Filter Normalized: denali vena cava filter |
Device | Bard Peripheral Vascular, Inc. | $532.42 | 1 | 2025 |
Source payment records
|
|||||
| Serrantor Normalized: serrantor |
Device | Cagent Vascular INC | $435.29 | 3 | 2025 |
Source payment records
|
|||||
| Venovo Normalized: venovo |
Device | Bard Peripheral Vascular, Inc., Becton, Dickinson and Company | $311.62 | 4 | 2025 |
Source payment records
|
|||||
| Penumbra System Normalized: penumbra system |
Device | Penumbra, Inc. | $265.26 | 7 | 2025 |
Source payment records
|
|||||
| LUTONIX Drug Coated Balloon Normalized: lutonix drug coated balloon |
Device | Bard Peripheral Vascular, Inc. | $233.78 | 2 | 2025 |
Source payment records
|
|||||
| Vascular Normalized: vascular |
Device | Artivion, Inc. | $219.96 | 5 | 2025 |
Source payment records
|
|||||
| ENROUTE Transcarotid Neuroprotection System Normalized: enroute transcarotid neuroprotection system |
Device | Boston Scientific Corporation | $210.77 | 6 | 2025 |
Source payment records
|
|||||
| AMDS-Ascyrus Medical Normalized: amds ascyrus medical |
Device | Artivion, Inc. | $199.03 | 3 | 2025 |
Source payment records
|
|||||
| COVERA Normalized: covera |
Device | Bard Peripheral Vascular, Inc. | $192.46 | 7 | 2025 |
Source payment records
|
|||||
| ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM Normalized: atricure cryoice cryosphere cryoablation system |
Device | AtriCure, Inc. | $179.59 | 2 | 2025 |
Source payment records
|
|||||
| Senza Normalized: senza |
Device | Globus Medical, Inc. | $179.16 | 5 | 2025 |
Source payment records
|
|||||
| GORE TAG Conformable Thoracic Endoprosthesis Normalized: gore tag conformable thoracic endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $162.71 | 7 | 2025 |
Source payment records
|
|||||
| IMPEDE EMBOLIZATION PLUG Normalized: impede embolization plug |
Device | Shape Memory Medical Inc. | $146.67 | 1 | 2025 |
Source payment records
|
|||||
| TREO ABDOMINAL STENT-GRAFT SYSTEM Normalized: treo abdominal stent graft system |
Device | Bolton Medical Inc | $136.58 | 1 | 2025 |
Source payment records
|
|||||
| ENDURANT IIS Normalized: endurant iis |
Device | Medtronic, Inc. | $120.00 | 1 | 2025 |
Source payment records
|
|||||
| AURYON LASER SYSTEM 100-120 VAC Normalized: auryon laser system 100 120 vac |
Device | AngioDynamics, Inc. | $112.64 | 3 | 2025 |
Source payment records
|
|||||
| ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER Normalized: on x aortic heart valve with conform x sewing ring and extended holder |
Device | Artivion, Inc. | $108.01 | 1 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN Endoprosthesis with Heparin Normalized: gore viabahn endoprosthesis with heparin |
Device | W. L. Gore & Associates, Inc. | $78.15 | 2 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN VBX Balloon Expandable Endo Normalized: gore viabahn vbx balloon expandable endo |
Device | W. L. Gore & Associates, Inc. | $70.24 | 4 | 2025 |
Source payment records
|
|||||
| Varithena Administration Pack Normalized: varithena administration pack |
Device | Boston Scientific Corporation | $62.56 | 2 | 2025 |
Source payment records
|
|||||
| JETSTREAM SC Normalized: jetstream sc |
Device | Boston Scientific Corporation | $61.48 | 4 | 2025 |
Source payment records
|
|||||
| Indigo System Normalized: indigo system |
Device | Penumbra, Inc. | $60.59 | 3 | 2025 |
Source payment records
|
|||||
| ENROUTE Transcarotid Stent Normalized: enroute transcarotid stent |
Device | Boston Scientific Corporation | $43.78 | 1 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN Endoprosthesis Normalized: gore viabahn endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $43.17 | 3 | 2025 |
Source payment records
|
|||||
| General - Thrombectomy Normalized: general thrombectomy |
Device | Boston Scientific Corporation | $41.17 | 1 | 2025 |
Source payment records
|
|||||
| RUBY Coil Normalized: ruby coil |
Device | Penumbra, Inc. | $37.90 | 3 | 2025 |
Source payment records
|
|||||
| MICRO ACCESS Normalized: micro access |
Device | AngioDynamics, Inc. | $37.11 | 1 | 2025 |
Source payment records
|
|||||
| General - Atherectomy Normalized: general atherectomy |
Device | Boston Scientific Corporation | $35.88 | 1 | 2025 |
Source payment records
|
|||||
| DIAMONDBACK PERIPHERAL Normalized: diamondback peripheral |
Device | Abbott Laboratories | $34.55 | 1 | 2025 |
Source payment records
|
|||||
| VENASEAL Normalized: venaseal |
Device | Medtronic, Inc. | $32.10 | 1 | 2025 |
Source payment records
|
|||||
| SET Aspirex S 10F 110cm Normalized: set aspirex s 10f 110cm |
Device | Bard Peripheral Vascular, Inc. | $30.88 | 2 | 2025 |
Source payment records
|
|||||
| Kerecis GraftGuide Normalized: kerecis graftguide |
Device | Kerecis Limited | $26.10 | 1 | 2025 |
Source payment records
|
|||||
| Kerecis SurgiClose Normalized: kerecis surgiclose |
Device | Kerecis Limited | $26.10 | 1 | 2025 |
Source payment records
|
|||||
| COLLAGENASE SANTYL Normalized: collagenase santyl |
Drug | Smith+Nephew, Inc. | $20.95 | 1 | 2025 |
Source payment records
|
|||||
| Whitening Pens Normalized: whitening pens |
Device | Philips North America LLC | $14.25 | 1 | 2025 |
Source payment records
|
|||||
| General - Ultrasound Normalized: general ultrasound |
Device | Boston Scientific Corporation | $12.42 | 1 | 2025 |
Source payment records
|
|||||
| EXCLUDER Conformable AAA Endoprosthesis with Active Control Normalized: excluder conformable aaa endoprosthesis with active control |
Device | W. L. Gore & Associates, Inc. | $6.43 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Clopidogrel | Clopidogrel Bisulfate | 105 | 30 |
| Xarelto | Rivaroxaban | 42 | 12 |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $158,544.94 · 270 records | Endologix LLC | AFX2 Bifurcated Endograft System, AMDS-Ascyrus Medical, ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM, AURYON LASER SYSTEM 100-120 VAC, Alto Abdominal Stent Graft System, COLLAGENASE SANTYL, COVERA, Crosser IQ, DIAMONDBACK PERIPHERAL, Denali Vena Cava Filter, ENDOCROSS Device, ENDURANT IIS, ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent, EXCLUDER Conformable AAA Endoprosthesis with Active Control, EkoSonic, GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis, GORE TAG Conformable Thoracic Endoprosthesis, GORE VIABAHN Endoprosthesis, GORE VIABAHN Endoprosthesis with Heparin, GORE VIABAHN VBX Balloon Expandable Endo, General - Atherectomy, General - Therapies, General - Thrombectomy, General - Ultrasound, General - Vascular Intervention, IMPEDE EMBOLIZATION PLUG, Indigo System, JETSTREAM SC, Kerecis GraftGuide, Kerecis SurgiClose, LUTONIX Drug Coated Balloon, MICRO ACCESS, ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER, Ovation iX Iliac Stent Graft, Penumbra System, Pristine, RUBY Coil, RotarexS 6 F x 135 cm, SET Aspirex S 10F 110cm, Senza, Serrantor, TREO ABDOMINAL STENT-GRAFT SYSTEM, Torus Stent Graft System, VENASEAL, Varithena Administration Pack, Vascular, Venclose Maven Catheter, Venovo, Whitening Pens | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error